PCM
Princeton Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Buy |
1,240
+23
| +2% | +$12.1K | 0.19% | 56 |
|
|
2025
Q1 | $772K | Sell |
1,217
-18
| -1% | -$11.4K | 0.27% | 50 |
|
|
2024
Q4 | $880K | Sell |
1,235
-10
| -0.8% | -$7.12K | 0.27% | 46 |
|
|
2024
Q3 | $1.31M | Sell |
1,245
-39
| -3% | -$41K | 0.41% | 41 |
|
|
2024
Q2 | $1.35M | Buy |
1,284
+392
| +44% | +$412K | 0.44% | 41 |
|
|
2024
Q1 | $859K | Buy |
892
+35
| +4% | +$33.7K | 0.31% | 53 |
|
|
2023
Q4 | $753K | Buy |
857
+14
| +2% | +$12.3K | 0.3% | 55 |
|
|
2023
Q3 | $694K | Hold |
843
| – | – | 0.32% | 56 |
|
|
2023
Q2 | $606K | Buy |
843
+85
| +11% | +$61.1K | 0.25% | 56 |
|
|
2023
Q1 | $623K | Sell |
758
-16
| -2% | -$13.1K | 0.27% | 60 |
|
|
2022
Q4 | $558K | Hold |
774
| – | – | 0.25% | 67 |
|
|
2022
Q3 | $533K | Buy |
774
+16
| +2% | +$11K | 0.23% | 64 |
|
|
2022
Q2 | $448K | Hold |
758
| – | – | 0.17% | 71 |
|
|
2022
Q1 | $529K | Sell |
758
-16
| -2% | -$11.2K | 0.16% | 71 |
|
|
2021
Q4 | $489K | Buy |
774
+89
| +13% | +$56.2K | 0.14% | 76 |
|
|
2021
Q3 | $415K | Hold |
685
| – | – | 0.13% | 79 |
|
|
2021
Q2 | $383K | Buy |
685
+13
| +2% | +$7.27K | 0.12% | 79 |
|
|
2021
Q1 | $318K | Buy |
+672
| New | +$318K | 0.11% | 84 |
|
|
2019
Q4 | – | Sell |
-265
| Closed | -$74K | – | 192 |
|
|
2019
Q3 | $74K | Hold |
265
| – | – | 0.04% | 128 |
|
|
2019
Q2 | $83K | Hold |
265
| – | – | 0.04% | 125 |
|
|
2019
Q1 | $109K | Sell |
265
-11
| -4% | -$4.53K | 0.06% | 114 |
|
|
2018
Q4 | $103K | Sell |
276
-197
| -42% | -$73.5K | 0.06% | 116 |
|
|
2018
Q3 | $191K | Sell |
473
-2,804
| -86% | -$1.13M | 0.08% | 100 |
|
|
2018
Q2 | $1.13M | Sell |
3,277
-49
| -1% | -$16.9K | 0.49% | 39 |
|
|
2018
Q1 | $1.15M | Sell |
3,326
-358
| -10% | -$123K | 0.51% | 40 |
|
|
2017
Q4 | $1.39M | Buy |
+3,684
| New | +$1.39M | 0.62% | 36 |
|